A UCL study found that 70% of young people with long Covid recovered within 24 months, but recovery was less likely among older teenagers, females, and those from deprived backgrounds. Researchers emphasized the need for further investigation and collaboration to address unresolved cases.
A new study led by UCL researchers reveals that most young individuals diagnosed with long Covid three months after a positive PCR test had fully recovered within 24 months.
The Children and young people with Long Covid (CLoCK) study, published in Nature Communications Medicine and funded by the National Institute for Health and Care Research (NIHR), is the world's largest longitudinal cohort study on long Covid in children.
The researchers, led by Professor Sir Terence Stephenson and Professor Roz Shafran (both UCL Great Ormond Street Institute of Child Health), asked young people aged 11 to 17 about their health three, six, 12 and 24 months after taking a PCR test for the Covid virus between September 2020 and March 2021. They also asked them to recall their symptoms at the time of taking the test.
In February 2022, the researchers published a consensus definition of long Covid which involved a young person having more than one symptom (such as tiredness, trouble sleeping, shortness of breath or headaches) alongside problems with either mobility, self-care, doing usual activities, having pain/discomfort, or feeling very worried or sad.
The researchers used this definition for their new study, which examined data from 12,632 young people who had a PCR test for SARS-CoV-2 (the virus that causes COVID-19). They found that around 25-30% of young people met the research definition of long Covid 24 months after their initial PCR test.
Study Results: Recovery Trends
Of the 12,632 young people in total, there were 943 who had tested positive when first approached and who provided answers at every time point: three, six, 12 and 24 months after their original test.
Of these 943 young people, 233 met the research definition of long Covid three months after their initial positive test. At six months,135 continued to meet the research definition of long Covid. At 12 months, 94 continued to fulfill the long Covid research definition.
However, only 68 of these 943 children and young people (7.2%) continued to fulfill the long Covid research definition when contacted 24 months after their initial positive test.
This means that 24 months after a proven Covid infection, 165 of the 233 young people (70%) who had long Covid three months after the infection and provided information at every time point in the research had recovered. But 68 of the 233 (30%) had not.
Key Demographic Findings
Older teenagers and the most deprived were less likely to have recovered. And, strikingly, females were almost twice as likely to still meet the research definition of long Covid at 24 months, compared to males.
However, the researchers note that they did not assess menstruation and some symptoms (such as headaches and tiredness) may be attributable to pre-menstrual syndrome given the high proportion of girls.
Study Chief Investigator and first author, Professor Sir Terence Stephenson, said: "Our findings show that for teenagers who fulfilled our research definition of long Covid three months after a positive test for the Covid virus, the majority have recovered after two years. This is good news but we intend to do further research to try to better understand why 68 teenagers had not recovered."
The CLoCK study is a major study funded by the National Institute for Health and Care Research (NIHR) and UK Research and Innovation (UKRI) to help improve understanding of the causes, symptoms, and treatment of the longer-term effects of Covid-19 in people who have not become unwell enough to be admitted to hospital.
The study was co-led by the UK Health Security Agency (UKHSA) in collaboration with researchers at Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH), Imperial College London, King's College London, Manchester University NHS Foundation Trust, the Universities of Bristol, Cambridge, Edinburgh, Liverpool, Manchester and Oxford, and University College London Hospitals NHS Foundation Trust. CLoCK also works closely with a patient and public involvement advisory group.
Following the 24-month results, data from all time points are now publicly available to other researchers.
The UCL researchers recently published a commentary, alongside colleagues at GOSH and the University of Brighton, on why better collaboration is needed between clinicians, interventionalists, epidemiologists, statisticians and those with lived experience to ensure a more effective, coordinated response ahead of future pandemics.
Study limitations
The symptoms reported by participants at the time of testing are subject to recall bias as they were reported at the time of first contact with the CLoCK study. However, three-month, six-month, 12-month, and 24-month symptoms were reported at the time they were being experienced.
Of the 31,012 children and young people invited to fill in a questionnaire 24-months post-PCR test, 12,632 of them participated and so this is a self-selected group which may introduce bias in the results.
Original PCR tests were taken before the Delta and Omicron variants became dominant, so the findings may not reflect the long-term effects of these variants.
Children and young people self-reported their symptoms. In some instances, such as to assess shortness of breath, it may have been better to conduct in-person medical interviews. However, this was not feasible or practical during the study period.
Importantly, the study primarily focuses on children and young people in England, and the findings may not be directly applicable to other populations or countries with different healthcare systems, vaccination rates, and demographics.
Reference: "A 24-month National Cohort Study examining long-term effects of COVID-19 in children and young people" by Terence Stephenson, Snehal M. Pinto Pereira, Manjula D. Nugawela, Emma Dalrymple, Anthony Harnden, Elizabeth Whittaker, Isobel Heyman, Tamsin Ford, Terry Segal, Trudie Chalder, Shamez N. Ladhani, Kelsey McOwat, Ruth Simmons, Laila Xu, Lana Fox-Smith, CLoCk Consortium and Roz Shafran, 4 December 2024, Communications Medicine.
DOI: 10.1038/s43856-024-00657-x
News
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]
Paralyzed Man Feels Sensation Again With Brain Stimulation Device
Aneuroprosthetic system has allowed a man with paralysis to grasp and lift objects and feel touch again. The device helped 42-year-old Keith Thomas of Massapequa, New York, who was paralyzed from the chest down [...]
Global Cancer Cases Could Surge 67% by 2050, New Report Warns
New data reveal major geographic disparities and highlight the urgent need for global action on prevention, early detection, and equitable access to treatment. For roughly one in five people worldwide, cancer will become part [...]
A Deadly Ebola-Like Virus Is Spreading. Are We Ready?
BU virologist Nancy Sullivan says the Bundibugyo outbreak in the Democratic Republic of the Congo underscores the need for broader outbreak preparedness. The death of a nurse marked the moment health officials recognized that [...]
Why Most Animal Viruses Never Become Human Pandemics
From receptor mismatch to risky human-animal interfaces, this article explains why spillover is common but true pandemic emergence remains rare. Introduction Humans are constantly exposed to animal viruses through farming, wildlife contact, and the [...]
Stem cell organoids repair heart microvessels in coronary artery disease models
A Stanford University team has shown that vascular organoids derived from human stem cells can repair the heart’s microvessel network in pigs with ischaemic heart disease – a proof-of-concept advancement that could open new therapeutic [...]
Goodbye GP waiting rooms, hello prevention at home
Prevention is suddenly everywhere in NHS reform. The recent £340m community pharmacy deal is moving more services onto the high street. Community Diagnostic Centres are being expanded, and the Neighbourhood Health Framework sets out [...]
Ebola control is weakened by mistrust and cultural insensitivity
Effective response depends on cooperation with communities and frontline workers, writes Zaeem ul Haq The current Bundibugyo Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda is exposing dangerous gaps in [...]
Building the Brain Requires Millions of Dangerous DNA Breaks
Scientists discovered that building a healthy brain involves an unexpected step: young neurons routinely break and rapidly repair their own DNA. As the brain develops, newly formed nerve cells must travel through tightly packed tissue [...]
One Tiny Change May Explain How Viruses Jump From Bats to Humans
Scientists found that one tiny genetic change may determine whether a bat virus stays in bats or becomes a human threat. Most infectious disease outbreaks begin when a virus or other pathogen crosses from animals into [...]
Scientists Discover 250+ Genes That Could Lead to New Ways To Prevent Melanoma
The world’s largest study of mole genetics identified hundreds of genes tied to melanoma risk, uncovering potential new drug targets and paving the way for more accurate melanoma screening and prevention. Researchers at QIMR [...]
Breakthrough Diabetes Treatment Reprograms the Immune System
An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking insulin-producing cells. For more than a century, people with Type 1 diabetes have relied [...]
Taking the world’s temperature: WHO chief spotlights global health emergencies
Taking the world’s temperature on pressing health matters, WHO Director-General Tedros Adhanom Ghebreyesus provided the latest on current global challenges - and successes when it comes to international cooperation. “The outbreaks of hantavirus, Ebola and Marburg all show [...]
Scientists Create Tiny “Mini Livers” That Could One Day Replace Liver Transplants
Engineered tissue grafts could help perform key liver functions and benefit thousands of people living with liver failure. The liver is one of the body’s hardest-working organs, carrying out hundreds of vital jobs, from [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]















